The Endocannabinoid System in Human Gestational Tissues in Labor

Completed

Conditions studied: Labor

In brief

The purpose of this research study is to determine if the endocannabinoid (a biological system) plays a role in the labor process.

Key facts

Study ID

NCT03752021

Run by

Wake Forest University Health Sciences

People needed

20

Starts

2019-01-25

Expected to finish

2019-07-01

Last updated by the study team

2019-08-15

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Pregnant women ages > 18 years old
• Pregnant women 22 weeks, 0 days through 42 weeks, 0 days gestation undergoing cesarean section
• Singleton gestation

You may not qualify if…

• Cannabinoid use during pregnancy
• Illicit drug use during pregnancy
• Nonsteroidal anti-inflammatory drug use within 7 days of cesarean section
• Maternal comorbidities including pre-existing diabetes, pre-existing hypertension, hypertensive disorders of pregnancy (preeclampsia, eclampsia), epilepsy currently being treated with antiepileptic medication, intraamniotic infection
• Uterine abnormalities
• Fetal anomalies
• Drug use or dependency

Where it is running

• Novant Health Forsyth Medical Center — Winston-Salem, North Carolina, United States
• Wake Forest University Health Sciences — Winston-Salem, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.